INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 November 2012
|
Total net assets |
£131.3m |
|
NAV per share |
236.7p |
|
Share price |
196.3p |
|
Total value of unquoted investments |
£22.2m |
|
Total number of portfolio companies |
65 |
|
Cash |
7% NAV |
|
Cash committed and reserved to unquoted investments |
(5)% NAV |
|
Portfolio companies with < 1 year of cash |
18.04% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen Celgene Gilead |
7.7 7.1 4.5 |
|
Aptiv |
4.3 |
|
Alexion |
3.7 |
|
Pharmaxis |
3.2 |
|
Onyx |
3.0 |
|
Insulet |
2.9 |
|
Actelion Jazz |
2.7 2.6 |
|
|
----------- |
|
Total |
41.7 |
|
Geographical Allocation |
% |
|
United States & Canada |
80 |
|
Europe |
10 |
|
Australia |
3 |
|
Cash |
7 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
76 |
|
Unquoted |
17 |
|
Cash |
7 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 DECEMBER 2012